Skip to main content

Envista Holdings Corp

corporate_fare Company Profile

Envista Holdings Corp

NVST·NYSE·Industrial Applications And Services·CIK 0001757073

Envista is a global dental products company with over 30 dental brands, including Nobel Biocare, Ormco, DEXIS, and Kerr. The company provides industry-leading products, solutions, and technology to dental professionals to support patient care. Its portfolio includes dental implants and treatment options, orthodontics, digital imaging technologies, restoratives, endodontics, rotary, infection prevention, and loupes. Envista was formed in 2018 as a wholly-owned subsidiary of Danaher Corporation and completed its initial public offering and separation from Danaher Corporation in 2019. The company serves dental professionals in over 130 countries through its commercial organization and distribution partners. In 2025, Envista generated total sales of $2.7 billion, with approximately 85% derived from sales of consumable products, services, and spare parts. The business operates through two segments: Specialty Products & Technologies, which includes Dental Implant Solutions and Orthodontic Solutions, and Equipment & Consumables, which includes Diagnostic and Consumables Solutions.

Envista Holdings Corp (NYSE:NVST) is a publicly traded company in the Industrial Applications And Services sector. Wiseek monitors NVST SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • Envista Crushes Q1 Estimates with 14% Sales Growth, Unveils New $300M Share Repurchase
  • Envista Holdings Reports Strong Q1 Earnings, Announces New $300M Stock Repurchase Program
  • Envista Holdings Reports Strong 2025 Financial Turnaround, Details Performance-Based Executive Pay
  • Envista Holdings Returns to Profitability in 2025, Reports No Goodwill Impairments, and Executes $166M Stock Repurchase
  • Envista Reports Strong Q4 & Full-Year 2025 Results, Initiates Positive 2026 Guidance

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$2.72B
Net Income
$47M
Diluted EPS
$0.28
Op. Cash Flow
$275.7M
Free Cash Flow
$230.4M
Gross Profit
$1.49B
Operating Income
$216.1M
Cash & Equivalents
$1.21B
Total Debt
$1.45B
Debt / Equity
0.47×
Net Margin
1.7%
Shares Outstanding
163.8M sh
Source: 10-K · filed 2026-02-12 · accession 0001757073-26-000011
Browse all tickers starting with N →
$24.6
52-week range · as of 2026-05-06 $16.32 – $30.42
Market cap
$4B
Volume
2.5M (0.7× avg)
3-mo avg 3.7M
Live data · 2026-06-14 03:52 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed NVST - Latest Insights

NVST
May 06, 2026, 4:48 PM EDT
Source: Reuters
Importance Score:
9
Price at Filing: $28.92
Real-time Price: $24.60 info
Change: -$4.32 (-15%) info
Market Cap: $4.003B info
NVST
May 06, 2026, 4:18 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $30.11
Real-time Price: $24.60 info
Change: -$5.51 (-18%) info
Market Cap: $4.003B info
NVST
Apr 07, 2026, 4:17 PM EDT
Filing Type: DEF 14A
Importance Score:
8
Price at Filing: $25.29
Real-time Price: $24.60 info
Change: -$0.690 (-3%) info
Market Cap: $4.003B info
NVST
Feb 12, 2026, 4:18 PM EST
Filing Type: 10-K
Importance Score:
8
Price at Filing: $28.77
Real-time Price: $24.60 info
Change: -$4.17 (-14%) info
Market Cap: $4.003B info
NVST
Feb 05, 2026, 4:11 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $26.25
Real-time Price: $24.60 info
Change: -$1.65 (-6%) info
Market Cap: $4.003B info